These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12748335)

  • 1. Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint.
    Locatelli F
    Nephrol Dial Transplant; 2003 Jun; 18(6):1061-5. PubMed ID: 12748335
    [No Abstract]   [Full Text] [Related]  

  • 2. Reflections on the HEMO study: the American viewpoint.
    Levin N; Greenwood R
    Nephrol Dial Transplant; 2003 Jun; 18(6):1059-60. PubMed ID: 12748334
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G; Beck GJ; Cheung AK; Daugirdas JT; Greene T; Kusek JW; Allon M; Bailey J; Delmez JA; Depner TA; Dwyer JT; Levey AS; Levin NW; Milford E; Ornt DB; Rocco MV; Schulman G; Schwab SJ; Teehan BP; Toto R;
    N Engl J Med; 2002 Dec; 347(25):2010-9. PubMed ID: 12490682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Friedman EA
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study.
    Ok E; Duman S; Asci G; Tumuklu M; Onen Sertoz O; Kayikcioglu M; Toz H; Adam SM; Yilmaz M; Tonbul HZ; Ozkahya M;
    Nephrol Dial Transplant; 2011 Apr; 26(4):1287-96. PubMed ID: 21148270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Locatelli F
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrologists should strive for optimal haemodialysis: the case of 8-hour thrice-weekly in-centre haemodialysis.
    Basile C; Lomonte C
    Nephrol Dial Transplant; 2011 Jul; 26(7):2419-20. PubMed ID: 21558428
    [No Abstract]   [Full Text] [Related]  

  • 8. Success and challenge in dialysis therapy.
    Himmelfarb J
    N Engl J Med; 2002 Dec; 347(25):2068-70. PubMed ID: 12490690
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients.
    Iseki K; Tozawa M; Takishita S
    Clin Exp Nephrol; 2003 Sep; 7(3):231-7. PubMed ID: 14586720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose.
    Depner T; Beck G; Daugirdas J; Kusek J; Eknoyan G
    Am J Kidney Dis; 1999 Jan; 33(1):142-9. PubMed ID: 9915282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients.
    Salahudeen AK; Dykes P; May W
    Nephrol Dial Transplant; 2003 Jul; 18(7):1339-44. PubMed ID: 12808171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Hoenich NA
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691050
    [No Abstract]   [Full Text] [Related]  

  • 13. The HEMO study - where do we go from here?
    Himmelfarb J
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):587-91. PubMed ID: 14564194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive home hemodialysis: the best treatment in the best system.
    Cornelis T; Kooman JP; van der Sande FM
    Nephrol Dial Transplant; 2011 Sep; 26(9):3067-8; author reply 3068. PubMed ID: 21677303
    [No Abstract]   [Full Text] [Related]  

  • 15. The never-ending search for the perfect dialysis. Should we move from the best treatment to the best system?
    Piccoli GB
    Nephrol Dial Transplant; 2011 Apr; 26(4):1128-31. PubMed ID: 21460360
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Scribner BH; Blagg CR
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12686708
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia].
    Alavi AA; Riabykina GV; Zaruba AIu; Kutsenko AI; Kukharchuk VV; Eliseev AO
    Ter Arkh; 1993; 65(4):58-60. PubMed ID: 8059409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of new hemodialysis membranes and equipment.
    Vanholder R; Glorieux G; Van Biesen W
    Nephron Clin Pract; 2010; 114(3):c165-72. PubMed ID: 19955821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.